[Chemoprevention of breast cancer: a hope justified?]
- PMID: 11014095
[Chemoprevention of breast cancer: a hope justified?]
Abstract
Chemoprevention of breast cancer, a dream? In one American study (National Surgical Adjuvant Breast and Bowel Project, NSABP-P1) tamoxifen decreased the incidence of invasive and non-invasive breast cancer, whereas in two English and Italian studies, it did not reduce this risk. Differences in the study population for the trials may underly these conflicting findings. New drugs, the SERMs, may be more promising.
Similar articles
-
Prevention of hormone-related cancers: breast cancer.J Clin Oncol. 2005 Jan 10;23(2):357-67. doi: 10.1200/JCO.2005.08.028. J Clin Oncol. 2005. PMID: 15637398 Review.
-
Chemoprevention of breast cancer.South Med J. 2001 Jan;94(1):7-15. South Med J. 2001. PMID: 11213947 Review.
-
National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.Clin Cancer Res. 2003 Jan;9(1 Pt 2):495S-501S. Clin Cancer Res. 2003. PMID: 12538506 Review.
-
Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.J Natl Cancer Inst. 2006 May 3;98(9):643; author reply 643-4. doi: 10.1093/jnci/djj167. J Natl Cancer Inst. 2006. PMID: 16670391 No abstract available.
-
Recent results from clinical trials using SERMs to reduce the risk of breast cancer.Ann N Y Acad Sci. 2006 Nov;1089:127-42. doi: 10.1196/annals.1386.010. Ann N Y Acad Sci. 2006. PMID: 17261762
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical